Topical pimecrolimus in the treatment of seborrheic dermatitis
Copyright policy )Topical pimecrolimus in the treatment of seborrheic dermatitis
Seborrheic dermatitis is a chronic inflammatory disease that mainly affects seborrheic areas of skin. An inflammatory response to the yeast Pityrosporum ovale has been thought to be important in the etiology of the condition. Therefore, topical antifungals and corticosteroids have been the mainstay of treatment. The recent development of topical macrolactam immunomodulators has offered a useful, safe alternative to corticosteroids in the treatment of various inflammatory skin disorders. We report successful treatment of seborrheic dermatitis with pimecrolimus.
- Baylor College of Medicine United States
- University of California, San Francisco United States
Adolescent, Administration, Topical, Face, Calcineurin Inhibitors, Humans, Female, Dermatologic Agents, Dermatitis, Seborrheic, Immunosuppressive Agents, Tacrolimus
Adolescent, Administration, Topical, Face, Calcineurin Inhibitors, Humans, Female, Dermatologic Agents, Dermatitis, Seborrheic, Immunosuppressive Agents, Tacrolimus
citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).32 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Top 10% impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 10%
Citations provided by BIP!Popularity provided by BIP!